Assignee

Kymera Therapeutics, Inc.

Patents = 32

Trademarks = 7

Forward Citations = 110

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

23 inventors (with patents filed for the assignee):

Kymera Therapeutics is a biotechnology company focused on developing breakthrough medicines that can selectively degrade disease-causing proteins. Using its proprietary targeted protein degradation platform, Kymera is able to discover and develop small molecules that can remove specific proteins from the body, offering a new approach for treating a wide range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com